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1. Introduction 
Transfusion-associated graft-versus-host disease (TA-GVHD) is a possible complication of 
blood transfusion that occurs when viable donor T-lymphocytes proliferate and engraft in 
immunodeficient patients after transfusion. Presently, the only method accepted to prevent 
TA-GVHD is the irradiation of blood and its components before transfusion (Moroff and 
Luban 1997)). Ionizing irradiation eliminates the functional and proliferative capacities of T-
lymphocytes leaving other blood components, especially erythrocytes, granulocytes and 
platelets, functional and viable. This is possible because T-lymphocytes are more 
radiosensitive than other blood components (Masterson and Febo, 1992).To carry out the 
irradiation of blood specially designed commercial irradiators exist, usually localized in 
blood banks, and dedicated exclusively to this task.  
Blood and blood components may be treated with ionizing radiation, such as gamma rays 
from 137Cs or 60Co sources, and from self-contained X-ray (bremsstrahlung) units and 
medical linear X-ray (bremsstrahlung) and electron accelerators used primarily for 
radiotherapy. However, teletherapy machines, such as linear accelerators or 60Co units 
already available at the hospital, may also be used for the same purpose (Moroff 1997), 
improving the cost/benefit ratio of the process. 
Blood irradiation specifications include a lower limit of absorbed dose, and may include an 
upper limit or central target dose. For a given application, any of these values may be 
prescribed by regulations that have been established on the basis of available scientific data. 
The absorbed dose range for blood irradiation is typically 15 Gy to 50 Gy. In some 
jurisdictions, the absorbed dose range for blood irradiation is 25 Gy to 50 Gy. The energy range 
is typically from approximately 40 keV to 5 MeV for photons, and up to 10 MeV for electrons. 
For each blood irradiator, an absorbed-dose rate at a reference position within the canister is 
measured by the manufacturer as part of acceptance testing using a reference-standard 
dosimetry system. That reference-standard measurement is used to calculate the timer setting 
required to deliver the specified absorbed dose to the center of the canister with blood and 
blood components, or other reference position. Either relative or absolute absorbed dose 
measurements are performed within the blood or blood-equivalent volume for determining 
the absorbed-dose distribution. Accurate radiation dosimetry at a reference position which 
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could be the position of the maximum absorbed dose (Dmax) or minimum absorbed dose 
(Dmin) offers a quantitative, independent method to monitor the radiation process. 
Dosimetry is part of a measurement quality assurance program that is applied to ensure that 
the radiation process meets predetermined specifications.  
2. Blood irradiators 
The basic operating principles and configurations of a free-standing irradiator with either 
137Cs  source or a linear accelerator are shown schematically in Figure 1. With a freestanding 
137Cs irradiator, the blood components are contained within a metal canister that is a 
rotating turntable. Continuous rotation allows for the   rays, originating from one to four 
closely positioned pencil sources, to penetrate all portions of the blood component. The 
number of sources and their placement depend on the instrument and model. The speed of 
rotation of the turntable also depends on the make or model of the instrument. A lead shield 
encloses the irradiation chamber. Free standing irradiators employing 60 Co as the source of 
  rays are comparable except that the canister containing the blood component does not 
rotate during the irradiation process; rather, tubes of 60 Co are placed in a circular array 
around the entire canister within the lead chamber. When free standing  irradiators are 
used, the  rays are attenuated as they pass through air and blood but at different rates.  The 
magnitude of attenuation is greater with 137Cs than with 60 Co. 
Linear accelerators generate a beam of X-rays over a field of given dimension. Routinely, the 
field is projected on a table-top structure. The blood component is placed (flat) between two 
sheets of biocompatible plastic several centimeters thick.The plastic on the top of the blood 
component (ie,nearer to the radiation source) generates electronic equilibrium of the 
secondary electrons at the point where they pass through the component container.The 
plastic sheet on the bottom of the blood component provides for irradiation back-scattering 
that helps to ensure the homogenous delivery of the x-rays. The blood component is usually 
left stationary when the entire x-ray dose is being delivered. Alternatively it may be flipped 
over when one half of the dose has been delivered; this process involves turning off and 
restarting the linear accelerator during the irradiation procedure. Although it seems as if the 
practice of flipping is not required,further data are needed. 
3. Blood components 
The risk of GVHD for patients, all components that might contain viable T lymphocytes 
should be irradiated. These include units of whole blood and cellular components (red cells, 
platelets, granulocytes),whether prepared from whole blood or by apheresis. All types of 
red cells should be irradiated, whether they are suspended in citrated plasma or in an 
additive solution. There are recent data supporting the retention of the quality of irradiated 
red cells after freezing and thawing.If frozen thawed units are intended for GVHD-
susceptible individuals and have not been previously irradiated,they should be irradiated 
because it is known that such components contain viable T lymphocytes.Filtered red cell 
products should also be irradiated.Extensive leucoreduction through filtration may decrease 
the potential for GVHD and serve as an alternative to irradiation in the future when 
questions about the minimum level of viable T lymphocytes that can lead to GVHD are 
resolved. There are reports of TA-GVHD in patients who received leucodepleted (filtered) 
red cells; however,the extent of leucoreduction of the components was not uniformly 
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quantified in such reports. In addition, investigators have suggested that the number of T 
lymphocytes present in a product that causes GVHD may depend on the extent of patient 
immunocompetence at the time of transfusion . It is likely that the greater the degree of 
immunosuppression, the fewer the viable T lymphocytes that will be required to produce 
GVHD in susceptible patients. In a recent review, it was suggested that cytotoxic T 
lymphocytes, or interleukin-2-secreting precursors of helper T lymphocytes,may be more 
predictive of GVHD than the number of proliferating T cells alone. Accordingly,this 
suggests that until further data are available to confirm adequate removal of these T-cell 
subtypes by leucoreduction, irradiation should be used for blood products destined for 
patients at risk for GVHD. Irradiated red cells undergo an enhanced efflux of potassium 
during storage at 10 to 60 C.Comparable levels of potassium leakage occur with or without 
prestorage leucoreduction. Washing units of red cells before transfusion to reduce the 
supernatant potassium load does not seem to be warranted for most red cell transfusions 
because posfinfusion dilution prevents the increase in plasma potassium. On the other hand, 
when irradiated red cells are used for neonatal exchange transfusion or the equivalent of a 
whole blood exchange is anticipated, red cell washing should be considered to prevent the 
possible adverse effects caused by hyperkalemia associated with irradiation and storage. 
Blood components given to recipients, whether immunocompromised or 
immunocompetent, that contain lymphocytes that are homozygous for an HLA haplotype 
that is shared with the recipient, pose a specific risk for TA-GVHD. This circumstance occurs 
when first and second degree relatives serve as directed donors s-ll and when HLA matched 
platelet components donated by related or unrelated individuals are being transfused.  
Irradiation of blood components has been recommended in these situations. 
Platelet components that have low levels of leucocytes because of the apheresis process 
and/or leucofiltration should also be irradiated if intended for transfusion to susceptible 
patients. This is because the minimum number of T lymphocytes that induces TA-GVHD 
has not yet been delineated. 
Fresh frozen plasma does not need to be irradiated routinely because it is generally accepted 
that the freezing and thawing processes destroy the T lymphocytes that are present in such 
plasma. 
During the past 2 years, there have been two brief articles suggesting that 
immunocompetent progenitor cells may be present in frozen-thawed plasma; the authors 
therefore suggested that frozen-thawed plasma may need to be irradiated.  Further studies 
are needed to validate these findings and to assess whether the number of 
immunocompetent cells, that may be present in thawed fresh frozen plasma, is sufficient to 
induce GVHD. In rare instances, when nonfrozen plasma (termed fresh plasma) is transfused, 
it should be irradiated because of the presence of a sizable number of viable lymphocytes, 
approximately 1 x10 7 cells in a component prepared from a unit of whole blood. 
4. Quality assurance guidelines 
Various dosimetry techniques have been used to measure the dose to blood products. 
These include thermoluminescent dosimeters (TLD); alanine, ferrous sulphate, red 
perspex, metaloxide semiconductor field effect transistors (MOSFETs) and chloroform 
/dithoizone/parafin mixture (Hillyer et al 1993). Recently radiochromic film was shown to 
be an adequate dosimeter for blood irradiation (Butson et al 1999). The most prevalent 
method relies on TLDs and tries to ascertain the causes and variations in delivered in vitro 
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dose across an ‘active’ treatment volume in a dedicated blood box for standard x-ray 
beams. 
Most dosimeters have significant energy dependence at photon and electron energies less 
than 100 keV, so great care must be exercised when measuring absorbed dose in that energy 
range. 
This practice outlines irradiator installation qualification, operational qualification, 
performance qualification, and routine product processing dosimetric procedures to be 
followed in the irradiation of blood and blood components by the blood-banking 
community. If followed, these procedures will help to ensure that the products processed 
with ionizing radiation from gamma, X-rays (bremsstrahlung), or electron sources receive 
absorbed doses within a predetermined range. 
One must document that the instrument being used for irradiation is operating appropriately 
and confirm that blood components had been irradiated.To assure that the irradiation process 
is being conducted correctly, specific procedures are recommended for free-standing 
irradiators and linear accelerators, which are summarized in Tables 1 and 2. The procedures to 
be used with free-standing irradiators are an update to the guidelines provided several years 
ago by Anderson. Included are current recommendations from the FDA. 
 
Measure Frequency
Isotop decay factor Annually for  137Cs ;montly for  60Co 
Dose map Annualy for 137Cs; annually  for  60Co 
Radiation leakage daily
Timer accuracy montly
Turntable daily
Table 1. Recommended Quality Assurance Measures to be Used with Free-Standing Gamma 
Irradiators. 
 
 
Fig. 1. With a freestanding 137Cs irradiator, the blood components are contained within a 
metal canister that is positioned on a rotating turntable. 
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Dose mapping measures the delivery of radiation within a simulated blood component or 
over an area in which a blood component is placed. This applies to an irradiation field when 
a linear accelerator is used or to the canister of a free-standing irradiator. Dose mapping is 
the primary means of ensuring that the irradiation process is being conducted correctly. It 
documents that the intended dose of irradiation is being delivered at a specific location 
(such as the central midplane of a canister), and it describes how the delivered irradiation 
dose varies within a simulated component or over a given area. This allows conclusions to 
be drawn about the maximum and minimum doses being delivered. Dose mapping should 
be performed with sensitive dosimetry techniques. A number of commercially available 
systems have been developed in recent years. Other quality assurance measures that need to 
be done include the routine confirmation that the turntable is operating correctly (for 137Cs 
rradiators), measurements to ensure that the timing device is accurate, and the periodic 
lengthening of the irradiation time to correct for source decay. With linear accelerators, it is 
necessary to measure the characteristics of the x-ray beam to ensure consistency of delivery. 
Confirming that a blood component has, in actuality, been irradiated is also an important 
part of a quality assurance program. At least one commercial firm has developed an 
indicator label for this purpose. 
5. Dose mapping with free-standing irradiators 
For free-standing irradiators, a dose-mapping procedure will measure the delivered dose 
throughout the circular canister in which the blood component is placed. To establish a two-
dimensional map, a dosimetry system is placed in a canister that is completely filled with a 
blood/tissue-compatible phantom composed of water or an appropriate plastic such as 
polystyrene.  The dosimetry material is placed within the phantom in a predetermined way. 
This approach provides data that describe the minimum levels of irradiation that would be 
absorbed by a blood component placed in the canister and recognizes that maximum 
attenuation will occur when the canister is completely filled with a blood-compatible 
material. Relevantly, it was shown recently that the absorbed dose at the central midplane of 
a canister (ie, at the center point) decreased by approximately 25% (from 3100 to 2500 cGy) 
in a  137Cs irradiator (JL Shepherd and Associates, San Francisco, CA) when the loading of 
the canister was changed from 0% (air) to 100% (with blood components). An 
irradiationsensitive film dosimetry system (International Speciality Products) that will be 
described later in this report was used for this purpose. A linear relationship was observed 
between the amount of fill and the measured central dose. With 1 and 2 units of blood 
components, the central dose relative to air was 0.98 and 0.93. The minimum and maximum 
levels were influenced in the same manner as the central dose on decreasing the proportion 
of the canister that contained air. Other studies have shown that the extent of variability in 
the dose delivered to the interior of simulated blood units (water or saline in plastic blood 
storage containers) depended on the model of the 137Cs free-standing irradiator.  An 
immobilized grid of thennoluminescent dosimeters in a plastic sheet were placed within the 
simulated blood units to measure dose delivery. See the section on dosimetry systems in 
use. It was also shown that a spacer into the bottom of the canister increases the minimum 
level of radiation within the simulated blood units as expected from the results of full-
canister dose mapping involving a phantom.The extent of variability with 137Cs  irradiations 
is influenced by a number of factors, including the number of sources, turntable speed, and 
the presence of a spacer at the bottom of the canister.These studies underscore the need for 
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consistency in loading the canister.Attenuation of the irradiation dose delivered is a function 
of physical density, electronic density, and atomic number with three major processes: 
photoelectric, Compton, and pair production. In practical terms, attenuation is caused when 
the irradiation enters a liquid, such as water or blood. The extent of attenuation depends on 
a number of factors,including the dimensions of the canister. In a fully filled canister, as is 
used for dose mapping, the attenuation will increase as the irradiation transverses to the 
center point. The dose map that is generated describes the dose distribution. As depicted in 
the theoretical dose map shown in Figure 2, the edges of the canister are exposed to a 
greater dose of irradiation compared with the center line because the attenuation is less in 
the periphery. The attenuation with 60 Co is less than that seen with 137Cs. 
When an irradiator is purchased, the distributor will provide a central dose level that is 
determined in a blood-compatible environment. In the 1970s and 1980s manufacturers 
provided a central dose that was determined in air, resulting in the use of timer settings that 
provided for a dose level that was somewhat less than what was expected. Subsequent to 
the issuing of the FDA guidelines in July 1993  and the use of dose mapping, it has been 
necessary to readjust irradiation times with some instruments because the attenuation effect 
had not been considered previously. 
A theoretical two-dimensional dose map describing the irradiation dose distribution 
through a fully filled canister of a free-standing  137Cs irradiator is shown in Figure 2. To 
obtain this dose map,dosimeters would have been positioned in the central axis and the 
edge of circular canister from the top to the bottom of the canister. The y dimension of the 
map depicts the top to bottom axis of the canister, whereas the x dimension depicts the 
cross-sectional axis. For the theoretical situation described in Figure 2, the central midplane 
dose is 2560 cGy, slightly above the minimum standard of 2500 cGy, and the minimum dose 
is 1750 cGy. In this irradiation dose map, the minimum dose is at the central bottom of the 
canister, a common finding in actual practice. 
The dose map can also be used to assess whether the turntable of a 137Cs irradiator is 
rotating in an appropriate manner. The occurrence of comparable readings at the two edges 
of the two-dimensional map, as depicted in the theoretical dose map, indicates that the 
canister is rotating evenly in front of the 137Cs source. If the turntable were not rotating, the 
dose levels at the edge of the map closest to the source would be much higher than that 
found on the opposite edge, ie, the side located distant to the source. According to the 1993 
recommendations from the FDA, dose mapping should be performed routinely on an 
annual basis and after a major repair, especially one involving the sample handling 
apparatus such as the turntable. 
6. Dosimetry systems  
The delivered irradiation dose can be measured by a variety of dosimetry systems. In recent 
years, several commercial interests have developed complete systems for use with free-
standing irradiators; each system consists of a phantom that fills the canister and a sensitive 
dosimetry system. Three main types of dosimetry measurement systems are available  
(Table 3).  
These dosimeters are referred to as routine dosimeters. They are calibrated against standard 
systems, usually at national reference laboratories such as the National Institute of 
Standards and Technology in the United States. The routine dosimeter measurement 
systems were initially developed for use with 137Cs irradiators because this is the 
www.intechopen.com
 
Blood Irradiation 
 
341 
predominant irradiation source for blood. More recently, they have been developed also for 
use with 60Co irradiators. Thermolumeniscent dosimeters (TLD chips) are one type of 
routine dosimeter. TLD chips are small plastic chips with millimeter dimensions having a 
crystal lattice that absorbs ionizing radiation. Specialized equipment is used to release and 
measure the energy absorbed by the TLD chip at the time of the test irradiation. In one 
commercially available system, chips are placed at nine different locations within a 
polystyrene phantom that fits into the canister of the IBL 437C irradiator (CIS US, 
Inc,Bedford, MA). The timer setting used routinely for an instrument is used in the test 
procedure. 
 
Method Measurement type 
Thermoluminescent Dosimetry Emission of light 
Radiochromic(GafChromic) film  Optic density 
Mosfet(metal –oxide field effect transistors) Voltage detection 
Alanine/ESR ESR signal-Magnetic field 
Table 3. Dosimetric systems in different clinics. 
There are two systems that use radiochromic film. On exposure to irradiation, the film 
darkens, resulting in an increase in optical density. The optical density, determined at 
various locations on the film, is linearly proportional to the absorbed irradiation dose. 
Standard films that are irradiated at a given dose level with a calibrated source at a national 
reference laboratory provide the means to assess the absolute level of absorbed 
irradiation.This type of dosimeter is basically an x-ray film  comparable with that used in 
clinical practice. With this device, the map that is developed identifies the absorbed 
irradiation dose that is measured at a large number of locations. In one system, a film 
contained in a thin water-tight casement is placed into the canister (International Specialty 
Products,Wayne, NJ), This approach is being used with a variety of irradiators. The canister 
is filled completely with water before the irradiation procedure.This system provides a 
direct readout of the dose that is delivered throughout the canister. The timer setting used 
routinely is employed for the test procedure. In a second system, a film having different 
radiation sensitive characteristics is embedded between two halves of a circular-fitting 
polystyrene plastic phantom (Nordion Internation, Canada, Ontario). Irradiation of 
specialized films is performed with a number of timer settings, each being larger than that 
used routinely. The map produced is normalized for a central midplane dose of 2500 cGy. 
The time to produce the 2500 cGy will have been predetermined with a different dosimeter 
system, the Fricke system, in which absorbed radiation causes a change in the state of a iron 
salt that can be assessed spectrophotometrically. Another approach to irradiation dose 
mapping employs a solid-state electronic dosimeter that is technically referred to as a metal-
oxide silicon field effect transistor (MOSFET). A board contains a number of small transistors in 
an arrangement that provides data for a dose map. This board is placed between two halves 
of a circular polystyrene phantom that fits into the canister. This dosimeter absorbs and 
stores the radiation dose imparted to it electronically . The radiation causes the formation of 
holes in the metal-oxide layer that becomes trapped within the transistor. The magnitude of 
the holes is evaluated by measuring the voltage across the transistor with a voltmeter. The 
voltages measured are converted to absorbed dose. With each dosimetry system, 
measurements are used to express the absorbed irradiation dose of cGrays. All dosimetry 
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measurements are associated with a degree of uncertainty or possible error. The magnitude 
of the uncertainty depends on the kind of dosimeter used. For most dosimeters, the level is 
5% of the measured value. For a central absorbed dose level of 2560 cGy (see theoretical 
dose map in Fig 2) the value could be as high as 2788 cGy or as low as 2432 cGy. 
Correspondingly, a measured value of 2400 cGy could be as high as 2520 cGy or as low as 
2380 cGy. Because the measured value could in actuality meet the 2500 cGy standard, it is 
appropriate to accept a value of 2400 cGy as meeting the current standard. The same 
approach should be used when evaluating the minimum value on a dose map. Albeit 
arbitrary and cautious, the actual minimum on an irradiation dose map should not be below 
1500 cGy. 
7. Precautions with free-standing irradiators 
It is important periodically to lengthen the time of irradiation to correct for decay of the 
isotopic source that emits the gamma irradiation. Until recently, this was the only major 
quality assurance measure that was performed routinely. With the half-life for 137Cs being 30 
years, annual lengthening of the timer setting is appropriate.On the other hand, with the 
half-life of  60Co being only 5,27 years, the time of irradiation should be increased on a 
quarterly basis. The additional seconds of irradiation that are needed can be calculated 
using formulae that can be found in any physics text. Alternatively, distributors of 
irradiators provide a chart that specifies the appropriate setting as a function of calendar 
time. 
7.1 Turntable rotation 
For 137Cs irradiators, it is essential that the turntable operates at a constant speed in a 
circular pattern to ensure that each part of a blood component is exposed equally to the 
source. Daily verification of turntable rotation is an appropriate quality assurance measure. 
With some free-standing irradiator models rotation of the turntable can be observed before 
the door of the compartment in which the canister is positioned is closed. In other models, 
this can be done only indirectly by ensuring that an indicator light is operating 
appropriately. With some older models, there have been occasional reports that the 
turntable failed to rotate because of mechanical problems. Such problems should not be 
encountered with the newer models because of changes in the turntable mechanisms. In any 
event, daily verification of turntable rotation is a prudent quality assurance measure. 
7.2 Radioactivity leakage 
Irradiators are constructed so that the isotopic sources are contained in a chamber heavily 
lined with a protective lead shield to prevent leakage of radioactivity. Accordingly, gamma 
irradiators are considered to be very safe instruments. Although there have been no reports 
of source leakage of radioactivity, periodic measurements are warranted to ensure that this 
is the case. Attaching a film badge to the outside of the irradiator, using a Geiger counter 
periodically, and performing a wipe test of the inside of the chamber where the canister is 
positioned at least semiannually are measures that are being used. 
8. Dose mapping with linear accelerators 
Linear accelerators that are used therapeutically to provide radiation therapy are carefully 
monitored to ensure appropriateness of dose to an irradiation field. When blood components 
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are treated with x-rays, the instrument settings are very different than those used to treat 
oncology patients. Hence, additional periodic quality control measures, primarily to assess 
the dose delivered to blood components, are needed to ensure that linear accelerators are 
being operated appropriately when used for blood irradiation. Currently, there are no 
commercially available systems for assessing the dose delivered throughout the area of an 
irradiation field in which blood components are placed for treatment with x-rays. An ideal 
dosimeter for this purpose would be made of a tissue-compatible plastic phantom, 
containing appropriate dosimeter material and a covering that could be placed at the 
appropriate distance from the source. An alternative approach might involve the use of a 
blood bag filled with water (simulating a blood unit) containing TLD chips, as described 
earlier. In comparative studies using such simulated blood units, it was determined that 
radiation delivery was more uniform with linear accelerators than with 137Cs free-standing 
irradiators.  This reflects the relative homogeneity of x-ray beams. In the absence of an 
available system modified for the irradiation of blood bags, the dose delivered throughout 
an irradiation field should be mapped with the dosimetric measuring system known as an 
ionization chamber. The ionization chamber is used to calibrate linear accelerators for patient 
use. In addition, on a yearly basis, dose mapping should be performed using a tissue-
compatible phantom. 
In view of the widely divergent conditions that are used during the operation of linear 
accelerators, other parameters pertaining to the x-ray beam should be evaluated on at least a 
quarterly basis to provide assurance that the instrument is being used appropriately for the 
irradiation of blood components. The goal is to ensure that the instrument is being set in a 
consistent fashion. When setting a linear accelerator for blood component irradiation, the 
following should be measured: the distance between the x-ray source and the position 
where the blood components are to be placed;  consistency in the strength of the x-ray beam; 
and (3) the intensity of the x-ray beam. The distance between the source and position on the 
table where blood components will be placed (referred to as the target) can be evaluated 
easily with a calibrated measuring device. This is a simple task that can be performed on a 
routine basis. The consistency of beam output can be evaluated by measuring the beam 
current. Beam intensity can be evaluated by measuring the ionization current in a 
monitoring ionization chamber array that can be expressed in terms of the number of 
photons delivered per square centimeter. These parameters should be assessed routinely as 
part of quality control programs used by radiation physicists. A code of practice was 
published in 1994 by the Radiation Therapy Committee of the American Association of 
Physicists in Medicine for the quality control of radiotherapy accelerators. The described 
practices are used routinely by radiation physicists. It would he prudent to ensure that an 
institution using a linear accelerator for blood irradiation follow these quality assurance 
guidelines and recommendations. 
9. Confirming that irradiation occurred 
It is important to have positive confirmation that the irradiation process has taken place. 
This is to identify whether an operator fails to initiate the electronically controlled 
irradiation process or when the irradiation process is not performed because of 
instrumentation malfunction. A radiation-sensitive indicator label has been developed 
specifically for this purpose by International Speciality Products,Wayne, NJ. The label 
containing a radiationsensitive film strip is placed on the external surface of the blood 
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component. Irradiation causes distinct visually observable changes: The appearance changes 
from clear red to opaque with obliteration of the word "NOT." When the label is placed on a 
blood component, there is a visual record that the irradiation process took place. The 
reliability of this type of indicator was documented recently in a multisite study.  
Two versions of the indicator label have been manufactured. The difference is the range of 
radiation needed to cause a change in the radiationsensitive film. The ratings for these 
indicators are 1500 cGy or 2500 cGy. The ratings serve as an approximate guideline for the 
amount of absorbed radiation that will be needed to completely change the window from 
reddish to opaque with complete obliteration of the word "NOT." Because the indicator 
labels are designed for and are used to confirm that the irradiation process has occurred, we 
have concluded that the 1500 cGy label is the most appropriate tool to perform this quality 
control measure. This is based on the routinely observed pattern of dose distribution to a 
blood component in a canister of a free-standing irradiator. Despite a targeted central dose 
of 2500 cGy, there will be spots at which the dose will be less. If the theoretical dose map 
presented in Figure 2 is used as an example, there will be a spot that will receive only 1800 
cGy. If the 2500 cGy-rated label were to be located on the external surface of a component, 
there may be minimal changes in the appearance of the radiation-sensitive film 
window.This would result in a judgment that the blood component was not irradiated, 
when in actuality it was treated satisfactorily. 
 
Dose
Linear accelerators Free standing irradiators 
2500 cGy  to the center of an irradiation field 
with a minumum of 1500 cGy elsewhere. 
2500 cGy to the central midplane of a 
canister with a minumum of 1500 cGy 
elsewhere.
Dose mapping
Linear accelerators Free Standing irradiators 
Yearly dose mapping with an ionization 
chamber and a water phantom.More 
frequent evaluation of instrument conditions 
to ensure consistency of x-rays. 
Routinely,once a year Cs-137 or twice a year 
Co-60 and after major repairs;the irradiation 
procedure should be tested using a fully 
filled canister with a dosimetry system to 
map the distrubition of the absorbed dose. 
Correction for radioisotopic decay
Cs-137; annually Co-60; every 3 month 
Turntable rotation(Free standing Cs-137 irradiators)
Daily should be checked.
Storage time (after irradiation)
Red cells Platelets
For up to 28 days;total storage time cannot 
exceed maximum stroga time for 
unirradiated red cells
No change due to the irradiation. 
Table 4. Guidelines for irradiating blood components. 
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